Miltiades Kyprianou

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

Evdoxia Kyriazopoulou, Haralampos Milionis, Symeon Metallidis et al. · Nature Medicine · 2021 · 539 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

An open label trial of anakinra to prevent respiratory failure in COVID-19

Evdoxia Kyriazopoulou, Periklis Panagopoulos, Symeon Metallidis et al. · eLife · 2021 · 192 citations · Full text

Medicine, Immunology, Pharmacotherapy +16

Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial

Evdoxia Kyriazopoulou, Lydia Liaskou-Antoniou, George Adamis et al. · American Journal of Respiratory and Critical Care Medicine · 2020 · 139 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Toward personalized immunotherapy in sepsis: The PROVIDE randomized clinical trial

Konstantinos Leventogiannis, Evdoxia Kyriazopoulou, Nikolaos Antonakos et al. · Cell Reports Medicine · 2022 · 125 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +17

Kinetics of circulating immunoglobulin M in sepsis: relationship with final outcome

Evangelos J. Giamarellos‐Bourboulis, Efterpi Apostolidou, Malvina Lada et al. · Critical Care · 2013 · 76 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +9